Description

Morpholine, 4-[[(1,4,5,6,7,8-Hexahydro-7-Methyl-4-Oxo[1]Benzothieno[2,3-D]Pyrimidin-2-Yl)Thio]Acetyl]- (9Ci) is a high-purity, complex heterocyclic compound that serves as a critical advanced pharmaceutical intermediate and a versatile building block in organic synthesis. Its molecular architecture, featuring fused benzothienopyrimidine and morpholine rings, makes it invaluable for the research and development of novel active pharmaceutical ingredients (APIs). This compound is primarily sought by pharmaceutical R&D laboratories and fine chemical manufacturers engaged in creating next-generation therapeutics, particularly in oncology and other specialized drug discovery fields.

Application

• Pharmaceutical Intermediate: A key synthetic precursor in the development of novel drug candidates, especially those targeting specific enzymatic pathways.
• Organic Synthesis Building Block: Used in complex multi-step syntheses to construct sophisticated heterocyclic frameworks for medicinal chemistry.
• Research & Development: Essential for academic and industrial research programs focused on benzothieno[2,3-d]pyrimidine derivatives and their biological activities.
• Chemical Reference Standard: Serves as a high-purity analytical standard for quality control and method development in pharmaceutical analysis.
• Ligand and Inhibitor Synthesis: Potential use in creating specialized ligands or enzyme inhibitors for biochemical and pharmacological studies.

Basic Information

Item	Detail
Product Name	Morpholine, 4-[[(1,4,5,6,7,8-Hexahydro-7-Methyl-4-Oxo[1]Benzothieno[2,3-D]Pyrimidin-2-Yl)Thio]Acetyl]- (9Ci)
CAS No.	606106-63-2
Molecular Formula	C18H21N3O3S2
Molecular Weight	407.51 g/mol
Synonyms	4-[[(1,4,5,6,7,8-Hexahydro-7-methyl-4-oxo[1]benzothieno[2,3-d]pyrimidin-2-yl)thio]acetyl]morpholine; 4-({[(7-Methyl-4-oxo-1,4,5,6,7,8-hexahydro[1]benzothieno[2,3-d]pyrimidin-2-yl)sulfanyl]acetyl})morpholine; N-[(7-Methyl-4-oxo-1,4,5,6,7,8-hexahydrobenzothieno[2,3-d]pyrimidin-2-yl)sulfanylacetyl]morpholine; 606106-63-2; 4-[(1,4,5,6,7,8-Hexahydro-7-methyl-4-oxo[1]benzothieno[2,3-d]pyrimidin-2-yl)sulfanylacetyl]morpholine
EINECS	Contact for details

Quality Control

Our production of this advanced intermediate adheres to strict quality management systems to ensure batch-to-batch consistency and high purity. Every lot is characterized using advanced analytical techniques including HPLC, NMR, and mass spectrometry. A comprehensive Certificate of Analysis (COA) detailing identity, purity, and impurity profiles is provided with each shipment, supporting your regulatory and R&D documentation needs.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated area at a controlled room temperature (typically 15-25°C). The compound may be moisture-sensitive; keep the container tightly sealed under an inert atmosphere if specified. Keep away from incompatible materials.

Specification

Item	Specification
Appearance	White to off-white crystalline powder
Identification (IR)	Conforms to structure
Identification (HPLC)	Retention time matches reference standard
Purity (HPLC)	≥ 97.0%
Water Content (KF)	≤ 0.5%
Residue on Ignition	≤ 0.1%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.